Theravance Biopharma Inc
TBPH | NASDAQ
$17.05
$0 (0.00%)
Sep 22, 2026, 9:42 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -5.9M | -4.93M | 61.02M | 3.62M | 54.84M | -13.58M | -15.53M | -12.7M | -16.53M | -11.66M | -8.51M | -8.95M | -15.65M | -22.09M | -14.26M | -15.52M | -22.79M | -40.26M | -32.03M | -75.17M | -52.41M | -79.68M |
Depreciation & Amortization | 2.05M | 835K | 430K | 636K | 927K | 1.05M | 695K | 762K | 979K | 1.18M | 1.42M | 937K | 924K | 978K | 2.03M | 1.77M | 1.91M | 1.32M | 2.39M | 2.61M | 2.42M | 2.29M |
Stock-Based Compensation | 5.99M | 4.5M | 4.48M | 4.58M | 4.54M | 4.88M | 5.83M | 4.96M | 5.38M | 5.23M | 5.82M | 6.26M | 6.26M | 7.02M | 6.95M | 8.53M | 9.71M | 14.55M | 16.92M | 14.37M | 14.94M | 15.83M |
Other Working Capital | 2.66M | -2.66M | 162.46M | -21.07M | 165.1M | -1.32M | 14.69M | 2.42M | 2.33M | 1.12M | -2.65M | -355K | -1.43M | -3.23M | 65.99M | -15.78M | 589K | -4.12M | -1.71M | -4.11M | -17.88M | -15.99M |
Other Non-Cash Items | 66.95M | 42K | -333.7M | 551K | 664K | 604K | 806K | 2.03M | 3.63M | 629K | 3.83M | 610K | 1.89M | 579K | -178.33M | -1.69M | -5.53M | 2.27M | -22.19M | 20.46M | -1.98M | 4.8M |
Deferred Income Tax | -218K | -3M | 30K | 994K | -10.69M | -1.85M | -6.59M | 90K | -561K | -513K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -77.75M | 75.83M | 261.67M | -16.88M | 157.8M | 51.94M | 13.89M | -342K | 2.69M | 4.12M | -3.41M | -1.35M | -5.87M | 2.29M | 59.56M | -15.23M | 1.97M | -3.95M | -7.52M | -7.71M | -13.09M | -13.11M |
Operating Cash Flow | -8.88M | 73.28M | -6.06M | -6.51M | 208.07M | 43.04M | -902K | -5.2M | -4.42M | -1.02M | -854K | -2.49M | -12.44M | -11.22M | -124.06M | -22.14M | -14.73M | -26.07M | -42.43M | -45.45M | -50.11M | -69.87M |
Capital Expenditures | n/a | n/a | -8K | n/a | -34K | n/a | -190K | -15K | -36K | -91K | -677K | -21K | -852K | -938K | -266K | 57K | -113K | -250K | -444K | -1.04M | -156K | -1.77M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -101.9M | -43.41M | -64.93M | -124.75M | -56.57M | -1.97M | -40.01M | -44.88M | -31.24M | -26.9M | n/a | n/a | -1K | -134.53M | -9.89M | -39.5M | -35.59M | -18.17M | -53.53M | -64.76M | -39.98M | -36K |
Sales Maturities Of Investments | 41.5M | 96M | 65.53M | 24.5M | 20.35M | 32.6M | 55.89M | 27.5M | 28.24M | 44.02M | n/a | n/a | 10.6M | 92.22M | 49.31M | 17.01M | 43.2M | 48.5M | 64.8M | 30M | 75.9M | 115.5M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.3M | 210K | n/a | 1.1B | 17K | 1.85M | n/a | 6K | n/a | n/a |
Investing Cash Flow | -60.4M | 52.59M | 588K | -100.25M | -36.26M | 30.63M | 15.69M | -17.4M | -3.03M | 17.03M | -677K | -21K | 11.05M | -43.05M | 39.16M | 1.08B | 7.52M | 31.92M | 10.82M | -35.79M | 35.77M | 113.7M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -631.6M | n/a | n/a | n/a | n/a | -5.03M | -5.7M |
Common Stock Repurchased | 5.82M | -5.82M | -1.98M | -678K | -503K | -874K | -528K | -397K | -463K | -1.72M | -30.78M | -31.4M | -81.13M | -56.24M | -35.79M | -94.7M | -347K | -1.45M | -455K | -2.29M | -727K | -5.59M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -967K | n/a | n/a | n/a | n/a | n/a | 133K | n/a | 375K | n/a | 173K | -1K | 446K | n/a | 314K | 4.28M | 487K | n/a | 604K | n/a | 2.86M | 3K |
Financial Cash Flow | 4.61M | -5.58M | -1.49M | -400K | -503K | -854K | -365K | -372K | -44K | -1.72M | -30.61M | -31.4M | -80.68M | -56.24M | -35.47M | -722.03M | 140K | -1.45M | 149K | -2.29M | 105.29M | -11.29M |
Net Cash Flow | -64.67M | 120.3M | -6.97M | -107.15M | 171.31M | 72.82M | 14.42M | -22.97M | -7.49M | 14.29M | -32.14M | -33.91M | -82.07M | -110.51M | -120.37M | 331.25M | -7.08M | 4.41M | -31.46M | -83.53M | 90.94M | 32.54M |
Free Cash Flow | -8.88M | 73.28M | -6.07M | -6.51M | 208.04M | 43.04M | -1.09M | -5.21M | -4.45M | -1.11M | -1.53M | -2.51M | -13.29M | -12.16M | -124.32M | -22.08M | -14.84M | -26.32M | -42.88M | -46.49M | -50.27M | -71.63M |
Adj. Free Cash Flow | -14.87M | 68.78M | -10.55M | -11.08M | 203.5M | 38.16M | -6.92M | -10.17M | -9.83M | -6.34M | -7.36M | -8.77M | -19.55M | -19.18M | -131.27M | -30.61M | -24.55M | -40.86M | -59.8M | -60.86M | -65.21M | -87.46M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -938K | -266K | 57K | -113K | -250K | -444K | -1.04M | -156K | -1.77M |
Growth CapEx | n/a | n/a | -8K | n/a | -34K | n/a | -190K | -15K | -36K | -91K | -677K | -21K | -852K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -8.88M | 73.28M | -6.06M | -6.51M | 208.07M | 43.04M | -902K | -5.2M | -4.42M | -1.02M | -854K | -2.49M | -12.44M | -12.16M | -124.32M | -22.08M | -14.84M | -26.32M | -42.88M | -46.49M | -50.27M | -71.63M |
Add to Watchlist
Select watchlists to add or remove TBPH